Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 280 | 259 | 450 | 258 | 0 |
| Cost of Goods | 15 | 0 | N/A | N/A | 0 |
| Gross Profit | 265 | 259 | 450 | 258 | 0 |
| Operating Expenses | 15,225 | 10,950 | 5,300 | 3,235 | 4,400 |
| Operating Income | -14,945 | -10,691 | -4,849 | -2,977 | -4,400 |
| Interest Expense | 831 | 17 | 0 | 57 | 0 |
| Other Income | 1,451 | -1,103 | -6,717 | 794 | -3,440 |
| Pre-tax Income | -14,326 | -11,811 | -11,566 | -2,239 | -7,840 |
| Net Income Continuous | -14,326 | -11,811 | -11,566 | -2,239 | -7,840 |
| Net Income | $-14,326 | $-11,811 | $-11,566 | $-2,239 | $-7,840 |
| EPS Basic Total Ops | -54.73 | -50.41 | -64.09 | -16.56 | -182.05 |
| EPS Basic Continuous Ops | -54.57 | -50.10 | -63.74 | -16.60 | -182.05 |
| EPS Diluted Total Ops | -63.37 | -50.41 | -64.09 | -16.56 | N/A |
| EPS Diluted Continuous Ops | -54.09 | -50.10 | -63.74 | -16.60 | N/A |
| EBITDA(a) | $-14,462 | $-10,560 | $-4,807 | $-2,967 | $-4,380 |